Construction To Begin On Gulf Biotech's $93 Million Insulin Plant
This article was originally published in PharmAsia News
Gulf Biotech, backed by global drug makers such as Merck, Helm and Linde, expects to begin construction soon on a $93 million insulin-production plant in Bahrain.
You may also be interested in...
The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.
The December 12 UK general election returned a Conservative majority, the scale or which few would have predicted. It means that the new government can press on with its plans for Brexit, the uncertainty now surrounding only when, not if.